The development of an objective, standardized and validated tool for the assessment of clinical outcome of brain tumor patients
ID
Source
Brief title
Condition
- Nervous system neoplasms malignant and unspecified NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Interobserver variability of the criteria of each neurologic examination domain
specified in the NANO scale
Secondary outcome
none
Background summary
The evaluation of response and progression in brain tumor patients is mainly
based on evaluation with MR imaging. Despite that the physical evaluation has a
central role, but as of today an objective and validated scale to assess
clinical progression and respons through a standardized physical eximination is
lacking. This study will develop such a scale.
Study objective
The development of an objective, standardized and validated tool for the
assessment of clinical outcome of brain tumor patients
Study design
220 brain tumor patients will undergo twice on one day by two a neurological
examination by two different phycisians and/or specialized nurses. The findings
will be recorded on a specially developed form.
Study burden and risks
The burden is minimal, there are no risks.
Brooline Avenue 450
Boston, MA MA 02215
US
Brooline Avenue 450
Boston, MA MA 02215
US
Listed location countries
Age
Inclusion criteria
suffering from a brain tumor
18 year or older
informed consent
Exclusion criteria
not able to undergo a physical examination
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL49229.078.14 |